Comprehensive assessment of the genomic landscape of breast cancer brain metastases reveals targetable alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors

被引：0
|
作者：
Giannoudis, Athina
Sokol, Ethan
Ramkissoon, Shakti H.
Bhogal, Talvinder
McGregor, Kimberly
Clark, Allison
Razis, Evangelia D.
Bartsch, Rupert
Huang, Richard S. P.
Palmieri, Carlo
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-PD4-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD4-09
引用
收藏
页数：3
相关论文
共 48 条
  • [41] Case report: Efficacy of immune checkpoint inhibitors for high tumour mutational burden malignant phyllodes tumours of the breast as revealed by comprehensive genomic profiling
    Katsuya, Hiroo
    Sano, Haruhiko
    Sano, Haruna
    Mihashi, Tatsuya
    Nakashima, Chiho
    Kai, Keita
    Kimura, Shinya
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [42] Comprehensive genomic profiling (CGP) reveals site-specific enrichment of immunotherapy biomarkers and targetable alterations in non-small cell lung cancer (NSCLC) metastasis
    Kaplan, Benjamin G.
    Huang, Richard S.
    Dennis, Lucas
    Albacker, Lee A.
    Frampton, Garrett M.
    Sokol, Ethan S.
    Sivakumar, Smruthy
    CANCER RESEARCH, 2022, 82 (12)
  • [43] Comprehensive genomic analysis with immunological parameters to obtain the biomarkers for immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC).
    Owada, Yuki
    Muto, Satoshi
    Takagi, Hironori
    Inoue, Takuya
    Watanabe, Yuzuru
    Yamaura, Takumi
    Fukuhara, Mitsuro
    Okabe, Naoyuki
    Matsumura, Yuki
    Hasegawa, Takeo
    Tanaka, Daisuke
    Ito, Emi
    Nanamiya, Hideaki
    Imai, Jun-ichi
    Isogai, Takao
    Watanabe, Shinya
    Suzuki, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [44] COMPREHENSIVE GENOMIC PROFILING COMPARING PRIMARY CNS LYMPHOMA TO SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA REVEALS BIOMARKERS INDICATING POTENTIAL BENEFIT FROM IMMUNE CHECKPOINT INHIBITORS
    Severson, Eric
    Vergilio, Jo-Anne
    Gay, Laurie
    Daniel, Sugganth
    Elvin, Julia
    Suh, James
    Covert, Mandy
    Brown, Charlotte
    Miller, Vincent
    Stephens, Philip
    Ross, Jeffrey
    Ramkissoon, Shakti
    NEURO-ONCOLOGY, 2017, 19 : 175 - 175
  • [45] Comprehensive Genomic Profiling Demonstrates Differences in Primary CNS Lymphoma and Systemic Diffuse Large B Cell Lymphoma and Reveals Biomarkers Indicating Potential Benefit from Immune Checkpoint Inhibitors
    Severson, Eric A.
    Vergilio, Jo-Anne
    Gay, Laurie M.
    Daniel, Sugganth
    Elvin, Julia A.
    Suh, James
    Miller, Vincent A.
    Stephens, Philip J.
    Ross, Jeffrey S.
    Ramkissoon, Shakti
    BLOOD, 2017, 130
  • [46] Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions
    Ranjan, Tulika
    Podder, Vivek
    Margolin, Kim
    Velcheti, Vamsidhar
    Maharaj, Arun
    Ahluwalia, Manmeet Singh
    CANCERS, 2024, 16 (19)
  • [47] Genomic landscape and peripheral blood biomarkers of advanced triple-negative breast cancer treated with immune checkpoint blockade: An exploratory analysis of the TQB2450-Ib-07 trial.
    Han, Yiqun
    Wang, Jiayu
    Sun, Tao
    Ouyang, Quchang
    Li, Jianwen
    Xu, Binghe
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Yoh, Kiyotaka
    Matsumoto, Shingo
    Furuya, Naoki
    Nishino, Kazumi
    Miyamoto, Shingo
    Oizumi, Satoshi
    Okamoto, Norio
    Itani, Hidetoshi
    Kuyama, Shoichi
    Nakamura, Atsushi
    Nishi, Koichi
    Fukuda, Ikue
    Tsuta, Koji
    Hayashi, Yuichiro
    Motoi, Noriko
    Ishii, Genichiro
    Goto, Koichi
    LUNG CANCER, 2021, 159 : 128 - 134
12345